Caley-Reidenbach Consulting, LLP
541-929-7435
contact AT caleyreidenbach.com 

Women's Health

General

Breast cancer and mammography

  • Needs assessment for a CME program for oncologists about using nontaxane microtubule dynamics inhibitors to treat metastatic breast cancer. Prepared May 2013. [BC, writer]

  • Modi S. First-line treatment for newly diagnosed HER2-positive metastatic breast cancer. Online CME presentation. Prepared March 2013. [FR, collaborating writer]

  • Hurvitz S. Recurrent, previously treated HER2-positive metastatic breast cancer. Online CME presentation. Prepared February 2013. [BAC, collaborating writer]

  • Clinical trial report about inflammatory local recurrence after breast-conserving therapy for breast cancer. Prepared September 2012. [FR, collaborating editor]

  • Needs assessment for CME program on managing pretreated metastatic breast cancer. Prepared May 2010. [BAC and FR, writers]

  • Benchmarking report on current third-line treatment of breast cancer. Prepared July 2009. [BAC, writer]

  • Slide sets on breast cancer-related abstracts and posters presented at the 2009 ASCO annual meeting. [BC, writer]

  • Detailed summaries of published journal articles about anti-angiogenic therapy for breast, colorectal, ovarian, and renal cancer, prepared June to September 2008. [FR, writer]

  • Three posters presented at the 2008 ASCO annual meeting about anti-angiogenic treatment of breast and ovarian cancer. [FR, collaborating writer]

  • Same-day Internet reports from the San Antonio Breast Cancer Symposium, prepared for CURE magazine, December 2008. [BAC, writer]

  • Caley BA. Renaissance surgery: using robotic arms, video cameras, and tiny incisions, cancer surgeons are changing what it means to go under the knife. CURE: Cancer Updates, Research and Education. 2008;7(4):8-16. (Includes report on oncoplastic surgery for breast cancer patients.)

  • Caley BA. In situ breast cancer: is it really cancer? CURE: Cancer Updates, Research and Education. 2006;5(4):18-23,28. Also wrote sidebar: Do women under 50 need mammograms?

  • Meeting report, national breast cancer advisory board. Prepared June 2005. [FR, writer]

  • Meeting report, national breast cancer advisory board. Prepared June 2004. [BAC, writer]

  • Caley BA and Reidenbach F. Expanding options for advanced breast cancer. CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.

  • Reidenbach F. Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol. 2002;3:393.

  • Reidenbach F. Novel predictor of breast cancer survival called the most powerful to date. Reuters news for physicians, 11-14-2002.

  • Reidenbach F. Genetic factors account for most of the population variation in breast density. Reuters news for physicians, 9-19-2002.

  • Reidenbach F. Anthracycline/taxane neoadjuvant chemotherapy advised for breast cancer. Reuters news for physicians, 4-9-2002.

  • Reidenbach F. Clues to why breast cancer more often fatal in African Americans. Reuters news for physicians, 2-7-2002.

  • Reidenbach F. Postmastectomy radiation may be warranted after response to chemotherapy. Reuters news for physicians, 1-30-2002.

  • Reidenbach F. Incident breast lesions found on MRI unlikely to be malignant. Reuters news for physicians, 12-2-1998.

  • Reidenbach F. Adjuvant chemotherapy prolongs survival in high-risk node-negative breast cancer. Reuters news for physicians, 10-30-1998.

  • Reidenbach F. More genetic links to breast cancer. Reuters news for the public, 3-31-1998.

Cervical cancer, HPV, and Pap screening

  • CME newsletter about the clinical and economic burden of cervical cancer. Prepared September 2006. [FR, writer]

  • Reidenbach F. Active HPV-16 infection relatively uncommon in HIV-infected women in US. Reuters news for physicians, 1-27-2003.

  • Reidenbach F. HPV-positive women with normal Pap at substantial risk of future abnormal Pap. Reuters news for physicians, 12-6-2002.

  • Reidenbach F. Public funding of Pap tests linked to lower rate of invasive cervical cancer. Reuters news for physicians, 7-5-2002.

  • Reidenbach F. Enhanced Pap testing cost effective for infrequent screening. Reuters news for physicians, 1-27-1999.

  • Reidenbach F. Newer Pap tests cost effective. Reuters news for the public, 1-26-1999.

  • Reidenbach F. Women can contract HPV from sex with women. Reuters news for physicians, 12-21-1998.

Contraception

  • Attendance at and report on an advisory board meeting about a depot contraceptive product, September 2010. [FR, writer]

  • Reidenbach F. ACOG encourages ready access to emergency contraception. Reuters news for physicians, 5-19-1999.

  • Reidenbach F. No added cardiovascular disease risk from newer oral contraceptives. Reuters news for physicians, 10-9-1998.

  • Reidenbach F. Laparoscopy called “procedure of choice” for reversal of tubal sterilization. Reuters news for physicians, 10-7-1998.

  • Reidenbach F. Low-dose combination oral contraceptives safe after gestational diabetes. Reuters news for physicians, 8-12-1998.

  • Reidenbach F. Emergency contraception highly acceptable to US women. Reuters news for the public, 7-15-1998.

Endometriosis

  • Report about endometrial ablation as a treatment for endometriosis. Prepared June 2013. [BAC and FR, writers]

  • Reidenbach F. HRT recommended with Gn-RH agonist treatment of endometriosis. Reuters news for physicians, 7-5-1999.

Gender differences

HIV/AIDS in women

  • Reidenbach F. Active HPV-16 infection relatively uncommon in HIV-infected women in US. Reuters news for physicians, 1-27-2003.

  • Reidenbach F. Dextrin sulfate safe and acceptable as a vaginal microbiocide. Reuters news for physicians, 12-12-2002.

  • Reidenbach F. Women might have better HAART outcomes than men. Reuters news for physicians, 3-13-2002.

Hormone replacement see Menopause

Infertility

  • Pair of slide decks about infertility drugs (a follicle-stimulating hormone and a progesterone insert). Prepared January 2012. [BAC, writer]

  • Reidenbach F. Conceiving solutions: New ways to preserve fertility during cancer treatment. CURE: Cancer Updates, Research and Education. 2002;1(4):22-26.

  • Reidenbach F. New method of preimplantation genetic diagnosis analyzes every chromosome. Reuters news for physicians, 10-1-2002.

  • Reidenbach F. Steroid reduces incidence of ovarian hyperstimulation in women at high risk. Reuters news for physicians, 9-27-2002.

  • Reidenbach F. Anesthetics do not appear to affect success of gamete intrafallopian transfer. Reuters news for physicians, 1-11-1999.

Menopause

  • Reidenbach F. Cardiac autonomic function better with combination HRT than estrogen alone. Reuters news for physicians, 6-19-2002.

  • Reidenbach F. Endogenous testosterone may protect postmenopausal women from CVD. Reuters news for physicians, 3-14-2002.

  • Reidenbach F. Estrogen-androgen therapy alters body composition in postmenopausal women. Reuters news for physicians, 6-23-1999.

  • Reidenbach F. Half-dose HRT regimen controls menopausal symptoms with less bleeding. Reuters news for physicians, 5-21-1999.

  • Reidenbach F. Estrogen replacement reduces plasma viscosity in postmenopausal women. Reuters news for physicians, 12-11-1998.

  • Reidenbach F. Estrogen replacement therapy benefits postmenopausal women with CHD. Reuters news for physicians, 8-27-1998.

  • Reidenbach F. HRT does not cut heart risk in heart patients. Reuters news for the public, 8-18-1998.

Menstrual migraine, PMS, and PMDD

  • Web-based news for physicians and patient education brochure about menstrual migraine. Prepared November 2007 to April 2008. [BAC and FR, writers]

  • Taylor D. The science of perimenstrual symptoms and syndromes. Adv Stud Med. 2005;5:228-241. [BAC and FR, collaborating writers]

  • Reidenbach F. Central GABA function altered in women with premenstrual dysphoric disorder. Reuters news for physicians, 10-2-2002.

Ovarian cancer

  • Detailed summaries of published journal articles about anti-angiogenic therapy for breast, colorectal, ovarian, and renal cancer. Prepared June to September 2008. [FR, writer]

  • Three posters for ASCO about anti-angiogenic treatment of breast and ovarian cancer. Prepared April 2008. [FR, collaborating writer]

  • Reidenbach F. Blood test may screen for ovarian cancer. Reuters news for the public, 8-25-1998.

Pregnancy, labor, and delivery

  • CME slide set and training manual about care of pregnant women with inflammatory bowel disease. Prepared May 2014. [FR, writer]

  • Needs assessment for CME program on pregnancy in women with diabetes. Prepared December 2011. [BAC and FR, writers]

  • Review article about treating allergic rhinitis and comorbid asthma during pregnancy. Prepared July 2005. [FR, collaborating writer]

  • Reidenbach F. Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.

  • Van Horn C and Barrett P. Pregnancy, delivery and post-partum experience of 54 women with ostomies. J Wound Ostomy Continence Nurs. 1997;24:151-162. [FR, collaborating writer]

  • Reidenbach F. Microarray technology may lead to improved assay for fetal Down syndrome. Reuters news for physicians, 9-5-2002.

  • Reidenbach F. Prenatal phenobarbital does not enhance infant neurodevelopment. Reuters news for physicians, 8-13-2002.

  • Reidenbach F. Dad’s genes may affect risk of problem pregnancy. Reuters news for the public, 1-7-2002.

  • Reidenbach F. Risk of C-section no higher after epidural. Reuters news for the public, 12-22-1998.

  • Reidenbach F. Pregnant women develop anti-adhesion antibodies to malaria. Reuters news for physicians, 10-29-1998.

  • Reidenbach F. Aspirin does not prevent preeclampsia. Reuters news for physicians, 3-11-1998.

Sexual dysfunction in women

  • "Disorders of Sexual Function" (slide set). American Geriatrics Society, July 2006. [BAC and FR, writers]

  • Caley BA and Reidenbach F. Making love---and loving it. In: Family Doctor: Your Essential Guide to Health and Wellbeing. Leawood, KS: American Academy of Family Physicians; 2005:180-181.